211 related articles for article (PubMed ID: 16825485)
21. Methyridine (2-[2-methoxyethyl]-pyridine]) and levamisole activate different ACh receptor subtypes in nematode parasites: a new lead for levamisole-resistance.
Martin RJ; Bai G; Clark CL; Robertson AP
Br J Pharmacol; 2003 Nov; 140(6):1068-76. PubMed ID: 14581174
[TBL] [Abstract][Full Text] [Related]
22. Pyrantel resistance alters nematode nicotinic acetylcholine receptor single-channel properties.
Robertson AP; Bjørn HE; Martin RJ
Eur J Pharmacol; 2000 Apr; 394(1):1-8. PubMed ID: 10771027
[TBL] [Abstract][Full Text] [Related]
23. Target sites of anthelmintics.
Martin RJ; Robertson AP; Bjorn H
Parasitology; 1997; 114 Suppl():S111-24. PubMed ID: 9309773
[TBL] [Abstract][Full Text] [Related]
24. Role of the putative transmembrane segment M3 in gating of neuronal nicotinic receptors.
Campos-Caro A; Rovira JC; Vicente-Agulló F; Ballesta JJ; Sala S; Criado M; Sala F
Biochemistry; 1997 Mar; 36(9):2709-15. PubMed ID: 9054579
[TBL] [Abstract][Full Text] [Related]
25. The action of pyrantel as an agonist and an open channel blocker at acetylcholine receptors in isolated Ascaris suum muscle vesicles.
Robertson SJ; Pennington AJ; Evans AM; Martin RJ
Eur J Pharmacol; 1994 Dec; 271(2-3):273-82. PubMed ID: 7535704
[TBL] [Abstract][Full Text] [Related]
26. Amino acids outside of the loops that define the agonist binding site are important for ligand binding to insect nicotinic acetylcholine receptors.
Liu Z; Han Z; Liu S; Zhang Y; Song F; Yao X; Gu J
J Neurochem; 2008 Jul; 106(1):224-30. PubMed ID: 18363827
[TBL] [Abstract][Full Text] [Related]
27. Actions of potent cholinergic anthelmintics (morantel, pyrantel and levamisole) on an identified insect neurone reveal pharmacological differences between nematode and insect acetylcholine receptors.
Pinnock RD; Sattelle DB; Gration KA; Harrow ID
Neuropharmacology; 1988 Aug; 27(8):843-8. PubMed ID: 3216964
[TBL] [Abstract][Full Text] [Related]
28. Anthelmintic actions on homomer-forming nicotinic acetylcholine receptor subunits: chicken alpha7 and ACR-16 from the nematode Caenorhabditis elegans.
Raymond V; Mongan NP; Sattelle DB
Neuroscience; 2000; 101(3):785-91. PubMed ID: 11113327
[TBL] [Abstract][Full Text] [Related]
29. Potentiation of acetylcholine receptors by divalent cations.
Lindstrom J
Mol Pharmacol; 2006 Jul; 70(1):5-7. PubMed ID: 16641314
[TBL] [Abstract][Full Text] [Related]
30. Paraherquamide and 2-deoxy-paraherquamide distinguish cholinergic receptor subtypes in Ascaris muscle.
Robertson AP; Clark CL; Burns TA; Thompson DP; Geary TG; Trailovic SM; Martin RJ
J Pharmacol Exp Ther; 2002 Sep; 302(3):853-60. PubMed ID: 12183640
[TBL] [Abstract][Full Text] [Related]
31. Novel positive allosteric modulators of the human α7 nicotinic acetylcholine receptor.
Arias HR; Gu RX; Feuerbach D; Guo BB; Ye Y; Wei DQ
Biochemistry; 2011 Jun; 50(23):5263-78. PubMed ID: 21510634
[TBL] [Abstract][Full Text] [Related]
32. Whole-cell patch-clamp recording of nicotinic acetylcholine receptors in adult Brugia malayi muscle.
Robertson AP; Buxton SK; Martin RJ
Parasitol Int; 2013 Dec; 62(6):616-8. PubMed ID: 23562945
[TBL] [Abstract][Full Text] [Related]
33. Strychnine, but not PMBA, inhibits neuronal nicotinic acetylcholine receptors expressed by rabbit retinal ganglion cells.
Renna JM; Strang CE; Amthor FR; Keyser KT
Vis Neurosci; 2007; 24(4):503-11. PubMed ID: 17900376
[TBL] [Abstract][Full Text] [Related]
34. Activation of endplate nicotinic acetylcholine receptors by agonists.
Auerbach A
Biochem Pharmacol; 2015 Oct; 97(4):601-608. PubMed ID: 26206191
[TBL] [Abstract][Full Text] [Related]
35. Contribution of valine 7' of TMD2 to gating of neuronal alpha3 receptor subtypes.
Nieves-Cintrón M; Caballero-Rivera D; Navedo MF; Lasalde-Dominicci JA
J Neurosci Res; 2006 Dec; 84(8):1778-88. PubMed ID: 17044037
[TBL] [Abstract][Full Text] [Related]
36. Agonist-induced hump current production in heterologously-expressed human alpha4beta2-nicotinic acetylcholine receptors.
Liu Q; Yu KW; Chang YC; Lukas RJ; Wu J
Acta Pharmacol Sin; 2008 Mar; 29(3):305-19. PubMed ID: 18298895
[TBL] [Abstract][Full Text] [Related]
37. Subunit-specific contribution to agonist binding and channel gating revealed by inherited mutation in muscle acetylcholine receptor M3-M4 linker.
Shen XM; Ohno K; Sine SM; Engel AG
Brain; 2005 Feb; 128(Pt 2):345-55. PubMed ID: 15615813
[TBL] [Abstract][Full Text] [Related]
38. Novel structural determinants of single-channel conductance in nicotinic acetylcholine and 5-hydroxytryptamine type-3 receptors.
Peters JA; Carland JE; Cooper MA; Livesey MR; Deeb TZ; Hales TG; Lambert JJ
Biochem Soc Trans; 2006 Nov; 34(Pt 5):882-6. PubMed ID: 17052220
[TBL] [Abstract][Full Text] [Related]
39. Novel acetylcholine and carbamoylcholine analogues: development of a functionally selective alpha4beta2 nicotinic acetylcholine receptor agonist.
Hansen CP; Jensen AA; Christensen JK; Balle T; Liljefors T; Frølund B
J Med Chem; 2008 Dec; 51(23):7380-95. PubMed ID: 18989912
[TBL] [Abstract][Full Text] [Related]
40. Beta3 subunits promote expression and nicotine-induced up-regulation of human nicotinic alpha6* nicotinic acetylcholine receptors expressed in transfected cell lines.
Tumkosit P; Kuryatov A; Luo J; Lindstrom J
Mol Pharmacol; 2006 Oct; 70(4):1358-68. PubMed ID: 16835356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
